![David Woodhouse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Woodhouse
Presidente presso
SURROZEN, INC.
Patrimonio netto: 51 994 $ in data 31/07/2026
Profilo
David J.
Woodhouse is currently Chief Executive Officer & Director at Nuvig Therapeutics, Inc. since 2025.
He is Chairman at Surrozen, Inc. since 2023 and Director at Surrozen Operating, Inc. since 2020.
Formerly, Dr. Woodhouse was Managing Director at Goldman Sachs & Co. LLC from 2002 to 2015.
He was Chief Executive & Financial Officer, Director at NGM Biopharmaceuticals, Inc. from 2018 to 2020.
He also worked as a Research Assistant at Amgen, Inc. Education includes undergraduate studies at the University of California, Santa Barbara, an MBA from Tuck School of Business at Dartmouth, and a doctorate from Stanford University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SURROZEN INC 0,02% | 13/05/2026 | 2.341 ( 0,02% ) | 51 994 $ | 31/07/2026 |
Posizioni attive di David Woodhouse
| Società | Posizione | Inizio |
|---|---|---|
| SURROZEN, INC. | Presidente | 01/04/2023 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direttore/Membro del Consiglio | 25/09/2020 |
Nuvig Therapeutics, Inc.
 Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Amministratore Delegato | 09/09/2025 |
Precedenti posizioni note di David Woodhouse
| Società | Posizione | Fine |
|---|---|---|
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2015 |
| AMGEN INC. | Corporate Officer/Principal | - |
| NGM BIOPHARMACEUTICALS, INC. | Amministratore Delegato | - |
Formazione di David Woodhouse
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
